To clarify the types of cell death that TRAIL induced in combination with miR-137, we assessed the effects of pan-caspase (Z-VAD), RIPK1 (Necrostatin 1S) and MLKL (Necrosulfonamide) inhibitors on cell density in the two GBM cell lines. The gene discussed is RIPK1; the disease is glioblastoma.